Skip to content

Sequential embryo transfer trial

Evaluating the effect of sequential day3/ day5 embryo transfer on Improvement of pregnancy rate in patients with repeated implantation failure

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200421047152N1
Enrollment
200
Registered
2020-06-28
Start date
2020-06-21
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent implantation failure. Complications of attempted introduction of fertilized ovum following in vitro fertilization

Interventions

Intervention 1: Intervention group: Embryo transfer will be done in two steps in this group.A good quality morola phase embryo will be transfered in 3rd day after fertilization. In the next step a g

Sponsors

Avicenna Research Institute
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Patients with history of implantation failure more than two times Age<40 At least 3 good quality embryo formation in embryology lab Normal endometrium Normal karyo-type

Exclusion criteria

Exclusion criteria: Hetero zygote thrombophilia panel > 2 Hydrop-salpinx Severe male factor Infertility

Design outcomes

Primary

MeasureTime frame
Clinical Pregnancy. Timepoint: 3rd- 4th week after embryo transfer. Method of measurement: Trans-vaginal ultrasound.

Secondary

MeasureTime frame
Chemical Pregnancy. Timepoint: two or three weeks after Embryo transfer. Method of measurement: Serum Beta HCG.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactProfessor Soheila Arefi

Iranian academic center for education culture and research

soheilaarefi@yahoo.com+98 21 23519

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026